Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2000
11/21/2000US6150584 Human antibodies derived from immunized xenomice
11/21/2000US6150508 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/21/2000US6150503 Phosphorylated fusion proteins
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150161 Methods for the diagnosis of glaucoma
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150141 Intron-mediated recombinant techniques and reagents
11/21/2000US6150137 Immunosuppressant target proteins
11/21/2000US6150135 Dirofilaria and brugia thioredoxin peroxidase type-2 (TPX-2) nucleic acid molecules, and uses thereof
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150125 Flea protease proteins and uses thereof
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150114 Method and reagent for monitoring blood levels of antiplantelet compounds
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections
11/21/2000US6149918 The cell line contains a human herpesvirus type 8 virus particle and does not contain epstein barr virus; for the production of antibodies or screening a biological sample of the human suspected of being infected with virus
11/21/2000US6149916 Methods of accelerating wound healing or of stimulating connective tissue cell growth using connective tissue growth factor
11/21/2000CA2038578C Delivery of agents
11/16/2000WO2000068420A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000WO2000068383A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000WO2000068382A1 PrP-LIKE GENE
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068371A1 Method of cell cultivation
11/16/2000WO2000068270A1 Antibodies and peptides for detection of plasmodium vivax
11/16/2000WO2000068262A1 Novel pollen antigen
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068243A1 Methods using mechanisms of action of aroa
11/16/2000WO2000068242A1 Collagen-binding proteins from enterococcal bacteria
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067795A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
11/16/2000WO2000067794A1 Methods for inhibiting cutaneous inflammation and hyperpigmentation
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000067791A1 Ccr4 antagonists in sepsis
11/16/2000WO2000067790A1 Method for treating tnf-receptor type-2-induced diseases
11/16/2000WO2000067785A2 Staphyloccocus aureus antigen-containing whole cell vaccine
11/16/2000WO2000067775A1 Fibroblast growth factor 15
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000039287A3 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037613A3 Human akt-3
11/16/2000WO2000037025A3 Antibodies to truncated vegf-d and uses thereof
11/16/2000WO2000036118A3 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
11/16/2000WO2000034784A9 Protein scaffolds for antibody mimics and other binding proteins
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000033874B1 Boron neutron capture therapy using pre-targeting methods
11/16/2000WO2000029015A3 INFLUENCING OF ANGIGENESIS USING CD66a
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000023466A3 Human rna binding proteins
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018916A3 Human genes and gene expression products
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO2000001713A3 Diacylglycerol acyl transferase proteins
11/16/2000WO1999058981A3 Diagnostic tests for alzheimer's disease
11/16/2000WO1999051186A3 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
11/16/2000DE19919225A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/16/2000DE19919149A1 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Of interferon alpha-2 derived peptide homodimers and peptide heterodimers
11/16/2000DE19919148A1 Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Interleukin 12 derived peptide homodimers and peptide heterodimers
11/16/2000CA2503110A1 Collagen-binding proteins from enterococcal bacteria
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000CA2373618A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
11/16/2000CA2373507A1 Prp-like gene
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2372854A1 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372585A1 Method of culturing cells
11/16/2000CA2372213A1 Antibodies and peptides for detection of plasmodium vivax
11/16/2000CA2371193A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/15/2000EP1052285A2 Method of inducing an antigen-specific anticytotoxic cell
11/15/2000EP1051625A1 Assessing risk for integrin antagonist/agonist mediated diseases
11/15/2000EP1051620A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
11/15/2000EP1051508A1 Pancreatic eukaryotic translation initiation factor-2alpha kinase
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051499A2 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
11/15/2000EP1051497A2 Human protein kinase molecules
11/15/2000EP1051493A2 Method for producing antibody fragments
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051488A2 Human growth factor homologs
11/15/2000EP1051487A1 Placental protein 13
11/15/2000EP1051486A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells
11/15/2000EP1051485A1 Trek-1 like two pore potassium channel
11/15/2000EP1051483A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051434A1 G protein-coupled receptor
11/15/2000EP1051432A2 Method for reducing immunogenicity of proteins
1 ... 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 ... 1494